Anticuerpos anti-calreticulina (calr) mutante y usos de estos
Se describen anticuerpos anti-calreticulina mutante (mutCALR). También se describen ácidos nucleicos, vectores, células, kits y composiciones farmacéuticas relacionadas. También se describen métodos para tratar o diagnosticar neoplasias mieloproliferativas con los anticuerpos anti-mutCALR. Anti-muta...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | STEWART, Shaun M BUONPANE, Rebecca A ZHOU, Jing LEI, Hsiang-Ting NASTRI, Horacio G REIS, Edimara S ZHAO, Yonghong CELIK, Hamza DELLER, Marc C MCQUIRTER, Leslie Brooke Epling WASS, Brittney Melissa MAYES, Patrick |
| description | Se describen anticuerpos anti-calreticulina mutante (mutCALR). También se describen ácidos nucleicos, vectores, células, kits y composiciones farmacéuticas relacionadas. También se describen métodos para tratar o diagnosticar neoplasias mieloproliferativas con los anticuerpos anti-mutCALR.
Anti-mutant calreticulin (mutCALR) antibodies are disclosed. Also disclosed are related nucleic acids, vectors, cells, kits, and pharmaceutical compositions. Methods of treating or diagnosing myeloproliferative neoplasms with the anti-mutCALR antibodies are also disclosed. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CO2024009042A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CO2024009042A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CO2024009042A23</originalsourceid><addsrcrecordid>eNrjZLB1zCvJTC5NLSrIL1ZIBLJ1kxNzilJBYjmZeYkKGiCupkJuaQlQMlWhUqG0GKgwJVUhtbgkv5iHgTUtMac4lRdKczMou7mGOHvophbkx6cWFyQmp-allsQ7-xsZGJkYGFgamBg5GhkTpwoAzGkwrQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Anticuerpos anti-calreticulina (calr) mutante y usos de estos</title><source>esp@cenet</source><creator>STEWART, Shaun M ; BUONPANE, Rebecca A ; ZHOU, Jing ; LEI, Hsiang-Ting ; NASTRI, Horacio G ; REIS, Edimara S ; ZHAO, Yonghong ; CELIK, Hamza ; DELLER, Marc C ; MCQUIRTER, Leslie Brooke Epling ; WASS, Brittney Melissa ; MAYES, Patrick</creator><creatorcontrib>STEWART, Shaun M ; BUONPANE, Rebecca A ; ZHOU, Jing ; LEI, Hsiang-Ting ; NASTRI, Horacio G ; REIS, Edimara S ; ZHAO, Yonghong ; CELIK, Hamza ; DELLER, Marc C ; MCQUIRTER, Leslie Brooke Epling ; WASS, Brittney Melissa ; MAYES, Patrick</creatorcontrib><description>Se describen anticuerpos anti-calreticulina mutante (mutCALR). También se describen ácidos nucleicos, vectores, células, kits y composiciones farmacéuticas relacionadas. También se describen métodos para tratar o diagnosticar neoplasias mieloproliferativas con los anticuerpos anti-mutCALR.
Anti-mutant calreticulin (mutCALR) antibodies are disclosed. Also disclosed are related nucleic acids, vectors, cells, kits, and pharmaceutical compositions. Methods of treating or diagnosing myeloproliferative neoplasms with the anti-mutCALR antibodies are also disclosed.</description><language>spa</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240808&DB=EPODOC&CC=CO&NR=2024009042A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240808&DB=EPODOC&CC=CO&NR=2024009042A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>STEWART, Shaun M</creatorcontrib><creatorcontrib>BUONPANE, Rebecca A</creatorcontrib><creatorcontrib>ZHOU, Jing</creatorcontrib><creatorcontrib>LEI, Hsiang-Ting</creatorcontrib><creatorcontrib>NASTRI, Horacio G</creatorcontrib><creatorcontrib>REIS, Edimara S</creatorcontrib><creatorcontrib>ZHAO, Yonghong</creatorcontrib><creatorcontrib>CELIK, Hamza</creatorcontrib><creatorcontrib>DELLER, Marc C</creatorcontrib><creatorcontrib>MCQUIRTER, Leslie Brooke Epling</creatorcontrib><creatorcontrib>WASS, Brittney Melissa</creatorcontrib><creatorcontrib>MAYES, Patrick</creatorcontrib><title>Anticuerpos anti-calreticulina (calr) mutante y usos de estos</title><description>Se describen anticuerpos anti-calreticulina mutante (mutCALR). También se describen ácidos nucleicos, vectores, células, kits y composiciones farmacéuticas relacionadas. También se describen métodos para tratar o diagnosticar neoplasias mieloproliferativas con los anticuerpos anti-mutCALR.
Anti-mutant calreticulin (mutCALR) antibodies are disclosed. Also disclosed are related nucleic acids, vectors, cells, kits, and pharmaceutical compositions. Methods of treating or diagnosing myeloproliferative neoplasms with the anti-mutCALR antibodies are also disclosed.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB1zCvJTC5NLSrIL1ZIBLJ1kxNzilJBYjmZeYkKGiCupkJuaQlQMlWhUqG0GKgwJVUhtbgkv5iHgTUtMac4lRdKczMou7mGOHvophbkx6cWFyQmp-allsQ7-xsZGJkYGFgamBg5GhkTpwoAzGkwrQ</recordid><startdate>20240808</startdate><enddate>20240808</enddate><creator>STEWART, Shaun M</creator><creator>BUONPANE, Rebecca A</creator><creator>ZHOU, Jing</creator><creator>LEI, Hsiang-Ting</creator><creator>NASTRI, Horacio G</creator><creator>REIS, Edimara S</creator><creator>ZHAO, Yonghong</creator><creator>CELIK, Hamza</creator><creator>DELLER, Marc C</creator><creator>MCQUIRTER, Leslie Brooke Epling</creator><creator>WASS, Brittney Melissa</creator><creator>MAYES, Patrick</creator><scope>EVB</scope></search><sort><creationdate>20240808</creationdate><title>Anticuerpos anti-calreticulina (calr) mutante y usos de estos</title><author>STEWART, Shaun M ; BUONPANE, Rebecca A ; ZHOU, Jing ; LEI, Hsiang-Ting ; NASTRI, Horacio G ; REIS, Edimara S ; ZHAO, Yonghong ; CELIK, Hamza ; DELLER, Marc C ; MCQUIRTER, Leslie Brooke Epling ; WASS, Brittney Melissa ; MAYES, Patrick</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CO2024009042A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>STEWART, Shaun M</creatorcontrib><creatorcontrib>BUONPANE, Rebecca A</creatorcontrib><creatorcontrib>ZHOU, Jing</creatorcontrib><creatorcontrib>LEI, Hsiang-Ting</creatorcontrib><creatorcontrib>NASTRI, Horacio G</creatorcontrib><creatorcontrib>REIS, Edimara S</creatorcontrib><creatorcontrib>ZHAO, Yonghong</creatorcontrib><creatorcontrib>CELIK, Hamza</creatorcontrib><creatorcontrib>DELLER, Marc C</creatorcontrib><creatorcontrib>MCQUIRTER, Leslie Brooke Epling</creatorcontrib><creatorcontrib>WASS, Brittney Melissa</creatorcontrib><creatorcontrib>MAYES, Patrick</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>STEWART, Shaun M</au><au>BUONPANE, Rebecca A</au><au>ZHOU, Jing</au><au>LEI, Hsiang-Ting</au><au>NASTRI, Horacio G</au><au>REIS, Edimara S</au><au>ZHAO, Yonghong</au><au>CELIK, Hamza</au><au>DELLER, Marc C</au><au>MCQUIRTER, Leslie Brooke Epling</au><au>WASS, Brittney Melissa</au><au>MAYES, Patrick</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Anticuerpos anti-calreticulina (calr) mutante y usos de estos</title><date>2024-08-08</date><risdate>2024</risdate><abstract>Se describen anticuerpos anti-calreticulina mutante (mutCALR). También se describen ácidos nucleicos, vectores, células, kits y composiciones farmacéuticas relacionadas. También se describen métodos para tratar o diagnosticar neoplasias mieloproliferativas con los anticuerpos anti-mutCALR.
Anti-mutant calreticulin (mutCALR) antibodies are disclosed. Also disclosed are related nucleic acids, vectors, cells, kits, and pharmaceutical compositions. Methods of treating or diagnosing myeloproliferative neoplasms with the anti-mutCALR antibodies are also disclosed.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_CO2024009042A2 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Anticuerpos anti-calreticulina (calr) mutante y usos de estos |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T19%3A13%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=STEWART,%20Shaun%20M&rft.date=2024-08-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECO2024009042A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |